XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Statements of Income (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenue        
Product sales $ 6,387,080 $ 6,814,384 $ 13,269,753 $ 12,665,598
Contract research and development 609,154 488,155 1,334,147 1,344,713
Total revenue 6,996,234 7,302,539 14,603,900 14,010,311
Cost of sales 1,353,169 1,740,814 3,151,535 3,125,992
Gross profit 5,643,065 5,561,725 11,452,365 10,884,319
Expenses        
Selling, general, and administrative 348,363 343,688 747,724 733,603
Research and development 1,030,504 768,188 1,936,229 1,526,556
Total expenses 1,378,867 1,111,876 2,683,953 2,260,159
Income from operations 4,264,198 4,449,849 8,768,412 8,624,160
Interest income 387,860 430,983 749,638 868,717
Income before taxes 4,652,058 4,880,832 9,518,050 9,492,877
Provision for income taxes 1,491,023 1,575,635 3,059,400 3,055,135
Net income $ 3,161,035 $ 3,305,197 $ 6,458,650 $ 6,437,742
Net income per share – basic (in dollars per share) $ 0.65 $ 0.68 $ 1.33 $ 1.33
Net income per share – diluted (in dollars per share) 0.65 0.68 1.33 1.33
Cash dividends declared per common share (in dollars per share) $ 1 $ 1 $ 2 $ 2
Weighted average shares outstanding        
Basic (in shares) 4,841,010 4,835,564 4,841,010 4,835,289
Diluted (in shares) 4,845,632 4,837,819 4,845,907 4,837,293